文献速递小儿眼科与斜弱视

全球弱视患病率及至2040年疾病负担预测:系统综述与荟萃分析

Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis.
PubMed 文献 · Br J Ophthalmol · 2019-11-08

PURPOSE: Amblyopia is a leading cause of vision impairment among children and young adults. Individual studies showed significant variations in the prevalence of amblyopia in different regions and age groups.…

要点

  • 全球弱视汇总患病率为1.44%,欧洲2.90%、北美2.41%高于亚洲1.09%、非洲0.72%。
  • 20岁以上人群患病率最高为3.29%,性别间患病率无差异。

核心结论

  • 弱视正成为全球重要的视觉问题,亟需设计并实施弱视筛查、治疗及相关公共卫生策略。

主要发现

  • 荟萃分析显示弱视汇总患病率为1.44%(95%CI 1.17%至1.78%)。
  • 欧洲患病率2.90%、北美2.41%,高于亚洲1.09%和非洲0.72%。
  • 20岁以上人群患病率最高为3.29%,性别间患病率无差异。

临床怎么用

  • 应重视弱视的全球疾病负担,推动弱视筛查、治疗及相关公共卫生策略的制定与实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Amblyopia is a leading cause of vision impairment among children and young adults. Individual studies showed significant variations in the prevalence of amblyopia in different regions and age groups. This study is to estimate the global prevalence of amblyopia by pooling its prevalence from the previous studies and to project the number of people affected through 2040. METHODS: We performed a systematic review and meta-analysis on the prevalence of amblyopia using data published before 20 October 2018. We estimated the prevalence rate of amblyopia and its 95% CI globally and by subgroups (eg, region and age). The prevalence data were applied to United Nations World Population Prospects to derive the projected number with amblyopia through 2040. RESULTS: A meta-analysis of 60 studies (1 859 327 subjects) showed that the pooled prevalence rate of amblyopia was 1.44% (95% CI 1.17% to 1.78%). Prevalences in Europe (2.90%) and North America (2.41%) were higher than in Asia (1.09%) and Africa (0.72%). The highest prevalence was found in subjects over 20 years old (3.29%). There was no difference in the prevalence between genders. We estimated 99.2 (95% CI 71.7 to 146.1) million people with amblyopia in 2019 worldwide, increasing to 175.2 (95% CI 81.3 to 307.8) million by 2030 and 221.9 (95% CI 83.7 to 429.2) million by 2040. CONCLUSIONS: The amblyopia is becoming a significant vision problem worldwide. It is of great importance to design and implement amblyopia screening, treatment and related public health strategies.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Fu Z, Hong H, Su Z, et al. Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis. Br J Ophthalmol. 2019. PMID: 31704700. doi:10.1136/bjophthalmol-2019-314759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。